# Harvard Bioscience Inc: Form DEF 14A, filed Jan 30, 2026

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: DEF 14A
- Filed: 2026-01-30
- Accepted by EDGAR: Jan 30, 2026, 17:15 ET
- Period: 2026-03-06
- Accession: 0001171843-26-000541
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184326000541/def14a_013026.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184326000541/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184326000541/def14a_013026.htm

Filed Jan 30, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-000541. Last ingested by Listed: Nov 11, 2026, 01:53 ET. No prices; not investment advice.
